Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Huerta Yepez, Sara ^a   Yoon, Nam K ^b   Hernandez Cueto, Angeles ^a   Mah, Vei ^b   Rivera Pazos, Clara M ^a   Chatterjee, Devasis ^c,e   Vega, Mario I ^d   Maresh, Erin L ^b   Horvath, Steve ^b   Chia, David ^b   Bonavida, Benjamin ^b   Goodglick, Lee ^b  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

^d CMN   (Mexico)

^e BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; OUTCOME ASSESSMENT; PREDICTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; SURVIVAL RATE; SURVIVAL TIME; TISSUE MICROARRAY; DISEASE COURSE; GENE EXPRESSION REGULATION; LUNG TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PHOSPHORYLATION; PROGNOSIS; SURVIVAL; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHORYLATION; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 79959249562     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-259     Document Type: Article

References (36)

1. Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, Sedivy JM, Kolch W. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 1999, 401(6749):173-177. 10.1038/43686, 10490027.
2. Yeung K, Janosch P, McFerran B, Rose DW, Mischak H, Sedivy JM, Kolch W. Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Molecular and cellular biology 2000, 20(9):3079-3085. 10.1128/MCB.20.9.3079-3085.2000, 85596, 10757792.
3. Yeung KC, Rose DW, Dhillon AS, Yaros D, Gustafsson M, Chatterjee D, McFerran B, Wyche J, Kolch W, Sedivy JM. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Molecular and cellular biology 2001, 21(21):7207-7217. 10.1128/MCB.21.21.7207-7217.2001, 99896, 11585904.
4. Granovsky AE, Rosner MR. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell research 2008, 18(4):452-457. 10.1038/cr.2008.43, 18379591.
5. Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R, Rhodes D, Keller PJ, Mizokami A, Dunn R, Chinnaiyan AM, Yao Z, Keller ET. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. The Prostate 2006, 66(3):248-256. 10.1002/pros.20319, 16175585.
6. Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. Journal of the National Cancer Institute 2003, 95(12):878-889. 10.1093/jnci/95.12.878, 12813171.
7. Chatterjee D, Bai Y, Wang Z, Beach S, Mott S, Roy R, Braastad C, Sun Y, Mukhopadhyay A, Aggarwal BB, Darnowski J, Pantazis P, Wyche J, Fu Z, Kitagwa Y, Keller ET, Sedivy JM, Yeung KC. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. The Journal of biological chemistry 2004, 279(17):17515-17523. 10.1074/jbc.M313816200, 14766752.
8. Baritaki S, Katsman A, Chatterjee D, Yeung KC, Spandidos DA, Bonavida B. Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. J Immunol 2007, 179(8):5441-5453.
9. Hagan S, Al-Mulla F, Mallon E, Oien K, Ferrier R, Gusterson B, Garcia JJ, Kolch W. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 2005, 11(20):7392-7397. 10.1158/1078-0432.CCR-05-0283, 16243812.
10. Al-Mulla F, Hagan S, Behbehani AI, Bitar MS, George SS, Going JJ, Garcia JJ, Scott L, Fyfe N, Murray GI, Kolch W. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol 2006, 24(36):5672-5679. 10.1200/JCO.2006.07.5499, 17179102.
11. Schuierer MM, Bataille F, Weiss TS, Hellerbrand C, Bosserhoff AK. Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncology reports 2006, 16(3):451-456.
12. Chatterjee D, Sabo E, Tavares R, Resnick MB. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome. Clin Cancer Res 2008, 14(10):2994-3001. 10.1158/1078-0432.CCR-07-4496, 18483365.
13. Minoo P, Zlobec I, Baker K, Tornillo L, Terracciano L, Jass JR, Lugli A. Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. American journal of clinical pathology 2007, 127(5):820-827. 10.1309/5D7MM22DAVGDT1R8, 17439843.
14. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nature reviews 2007, 7(6):415-428.
15. Moreno-Bueno G, Portillo F, Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008, 27(55):6958-6969. 10.1038/onc.2008.346, 19029937.
16. Beach S, Tang H, Park S, Dhillon AS, Keller ET, Kolch W, Yeung KC. Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. Oncogene 2008, 27(15):2243-2248. 10.1038/sj.onc.1210860, 2933472, 17952120.
17. Corbit KC, Trakul N, Eves EM, Diaz B, Marshall M, Rosner MR. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. The Journal of biological chemistry 2003, 278(15):13061-13068. 10.1074/jbc.M210015200, 12551925.
18. Lorenz K, Lohse MJ, Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 2003, 426(6966):574-579. 10.1038/nature02158, 14654844.
19. Mah V, Seligson DB, Li A, Marquez DC, Elshimali Y, Fishbein MC, Chia D, Pietras RJ, Goodglick L. Aromatase expression predicts survival in women with early-stage non small cell lung cancer. Cancer research 2007, 67(21):10484-10490. 10.1158/0008-5472.CAN-07-2607, 17974992.
20. Seligson DB, Horvath S, McBrian MA, Mah V, Yu H, Tze S, Wang Q, Chia D, Goodglick L, Kurdistani SK. Global levels of histone modifications predict prognosis in different cancers. Am J Pathol 2009, 174(5):1619-1628. 10.2353/ajpath.2009.080874, 2671251, 19349354.
21. Jazirehi AR, Ng CP, Gan XH, Schiller G, Bonavida B. Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis. Clin Cancer Res 2001, 7(12):3874-3883.
22. Zaravinos A, Kanellou P, Baritaki S, Bonavida B, Spandidos DA. BRAF and RKIP are significantly decreased in cutaneous squamous cell carcinoma. Cell cycle Georgetown, Tex 2009, 8(9):1402-1408. 10.4161/cc.8.9.8308, 19342899.
23. Keller ET, Fu Z, Yeung K, Brennan M. Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene. Cancer letters 2004, 207(2):131-137. 10.1016/j.canlet.2004.02.006, 15151133.
24. Lee HC, Tian B, Sedivy JM, Wands JR, Kim M. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology 2006, 131(4):1208-1217. 10.1053/j.gastro.2006.07.012, 2593881, 17030190.
25. Zlobec I, Baker K, Minoo P, Jass JR, Terracciano L, Lugli A. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Clin Cancer Res 2008, 14(1):143-148. 10.1158/1078-0432.CCR-07-1380, 18172264.
26. Li HZ, Wang Y, Gao Y, Shao J, Zhao XL, Deng WM, Liu YX, Yang J, Yao Z. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res 2008, 6(6):917-928. 10.1158/1541-7786.MCR-08-0093, 18567796.
27. Rath O, Park S, Tang HH, Banfield MJ, Brady RL, Lee YC, Dignam JD, Sedivy JM, Kolch W, Yeung KC. The RKIP (Raf-1 Kinase Inhibitor Protein) conserved pocket binds to the phosphorylated N-region of Raf-1 and inhibits the Raf-1-mediated activated phosphorylation of MEK. Cellular signalling 2008, 20(5):935-941. 10.1016/j.cellsig.2008.01.012, 18294816.
28. Huang J, Mahavadi S, Sriwai W, Grider JR, Murthy KS. Cross-regulation of VPAC(2) receptor desensitization by M(3) receptors via PKC-mediated phosphorylation of RKIP and inhibition of GRK2. American journal of physiology 2007, 292(3):G867-874.
29. Granovsky AE, Clark MC, McElheny D, Heil G, Hong J, Liu X, Kim Y, Joachimiak G, Joachimiak A, Koide S, Rosner MR. Raf kinase inhibitory protein function is regulated via a flexible pocket and novel phosphorylation-dependent mechanism. Molecular and cellular biology 2009, 29(5):1306-1320. 10.1128/MCB.01271-08, 2643833, 19103740.
30. Jazirehi AR, Huerta-Yepez S, Cheng G, Bonavida B. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis. Cancer research 2005, 65(1):264-276.
31. Jazirehi AR, Vega MI, Chatterjee D, Goodglick L, Bonavida B. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. Cancer research 2004, 64(19):7117-7126. 10.1158/0008-5472.CAN-03-3500, 15466208.
32. Baritaki S, Chapman A, Yeung K, Spandidos DA, Palladino M, Bonavida B. Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction. Oncogene 2009,
33. Eves EM, Shapiro P, Naik K, Klein UR, Trakul N, Rosner MR. Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Molecular cell 2006, 23(4):561-574. 10.1016/j.molcel.2006.07.015, 1626587, 16916643.
34. Zhu J, Woods D, McMahon M, Bishop JM. Senescence of human fibroblasts induced by oncogenic Raf. Genes & development 1998, 12(19):2997-3007. 10.1101/gad.12.19.2997, 21698796.
35. Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Molecular and cellular biology 1997, 17(9):5598-5611. 232408, 9271435.
36. Houben R, Vetter-Kauczok CS, Ortmann S, Rapp UR, Broecker EB, Becker JC. Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma. The Journal of investigative dermatology 2008, 128(8):2003-2012. 10.1038/jid.2008.30, 18323787.